Enzymatic Nanomotors Integrated with Plant Extracts: Biochemical Mechanisms, Applications, and Clinical Perspectives
Molecules · 03.07.2026 · 31 (13) · 2344
DOI: 10.3390/molecules31132344 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 03.07.2026. Verfasst von Joanna Lemanowicz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biochemistry, Faculty of Medicine, Bydgoszcz University of Science and Technology, Bernardyńska 6 St., 85-029 Bydgoszcz, Poland. Hauptthemen laut MEDLINE: Plant Extracts, Enzymes. Die Arbeit nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Enzymatic nanomotors (EMNMs) represent an emerging class of intelligent nanosystems that exploit enzymatic biocatalysis to generate autonomous motion within biological environments, including complex cellular and tissue contexts within living organisms. Owing to their ability to utilize endogenous biofuels, high biocompatibility, and capacity for targeted propulsion, EMNMs have demonstrated considerable potential in diverse biomedical applications. These include targeted drug delivery, cancer therapy, diagnostics, and bioimaging, as well as the traversal of biological barriers. This review comprehensively discusses the mechanisms underlying enzyme-driven propulsion, nanomotor design strategies, and their current and prospective applications in medicine, while also addressing major challenges associated with enzymatic stability, biocompatibility, motion control, and clinical safety. Furthermore, future perspectives are highlighted, including enzyme cascade systems, intelligent nanomotor swarms, biodegradable materials, and strategies facilitating clinical translation. As a representative example of practical application, curcumin was employed as a model therapeutic agent due to its well-established anticancer, anti-inflammatory, and antioxidant properties, enabling evaluation of the nanomotors’ capability for controlled, pH-responsive release of therapeutic cargo. Nanophytomedicine enhances the therapeutic efficacy of phytochemicals by improving their stability, bioavailability, and targeted delivery through nanocarrier systems. The integration of phytotherapy with nanotechnology offers promising opportunities for the development of safer and more effective therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Biochemistry, Faculty of Medicine, Bydgoszcz University of Science and Technology, Bernardyńska 6 St., 85-029 Bydgoszcz, Poland.
- Department of Clinical Pharmacy, Medical College, Jagiellonian University, Medyczna 9, 30-688 Krakow, Poland.
- Department of Agronomy and Food Processing, Faculty of Agriculture and Biotechnology, Bydgoszcz University of Science and Technology in Bydgoszcz, 7 Kaliskiego St., 85-796 Bydgoszcz, Poland.
ORCID-Profile: Joanna Lemanowicz, Kinga Gawlińska
Zitieren
APA
Lemanowicz, J., Gawlińska, K., Jaskulska, I., Leśniak, E., & Kuczyński, A. (2026). Enzymatic Nanomotors Integrated with Plant Extracts: Biochemical Mechanisms, Applications, and Clinical Perspectives. Molecules, 31(13), 2344. https://doi.org/10.3390/molecules31132344
Vancouver
Lemanowicz J, Gawlińska K, Jaskulska I, Leśniak E, Kuczyński A. Enzymatic Nanomotors Integrated with Plant Extracts: Biochemical Mechanisms, Applications, and Clinical Perspectives. Molecules. 2026;31(13):2344. doi:10.3390/molecules31132344
BibTeX
@article{Lemanowicz2026,
author = {Lemanowicz, Joanna and Gawlińska, Kinga and Jaskulska, Iwona and Leśniak, Emilia and Kuczyński, Antoni},
title = {Enzymatic Nanomotors Integrated with Plant Extracts: Biochemical Mechanisms, Applications, and Clinical Perspectives},
journal = {Molecules},
year = {2026},
volume = {31},
number = {13},
pages = {2344},
doi = {10.3390/molecules31132344}
}
EUVIMED